Navigation Links
Genstruct Names Louis Latino VP of Sales
Date:9/17/2008

CAMBRIDGE, Mass., Sept. 17 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics and molecular diagnostics, announced today that it has appointed Louis Latino as VP of Sales. As part of Genstruct's executive management team, Mr. Latino will lead the company's global sales efforts, focusing on building the company's sales infrastructure to drive future growth.

In his role as VP of Sales, Mr. Latino will be responsible for managing and expanding partnerships with existing customers while leveraging the Genstruct platform to expand the company's consulting services and partnership business through the development of new partnerships and collaborations within the global biotechnology, pharmaceutical and related industries.

"Earlier this year we launched our Consulting Services division, and we have rapidly grown this business to the point that we need to build a world- class sales team to manage its growth. Lou Latino has both the experience and expertise we need to manage the growth of this business," said Keith O. Elliston, Ph.D., president and CEO of Genstruct. "He is ideally suited to extend the impact of the Genstruct platform throughout the life sciences sector. His wealth of management experience with early-stage companies and his outstanding sales record in the life sciences industry are the key qualities we need to expand our current partnerships and our customer base."

"Genstruct's Causal Network(TM) modeling platform has been vital to the development of safe and effective new drugs for our partners," said Mr. Latino. "As Genstruct's team of scientists and technology experts focus on new approaches to better understand and treat complex diseases, I see this as an opportunity to leverage the company's successes to broaden its impact across the industry."

Mr. Latino has nearly 30 years of senior sales management and direct sales experience. Prior to joining Genstruct, he was VP of North America, Life Sciences Sales and Support for Accelrys, Inc., a developer of a broad range of technologies, including computer-aided-molecular-design and scientific business intelligence software. He honed his life sciences expertise as VP of Worldwide Sales for Geneformatics and as a regional sales manager for Biosym Technologies. In both positions, he exceeded revenue goals and increased profitability for the respective companies, while enhancing the impact of their technologies.

Mr. Latino has also held senior sales positions with Superscape Group, Mitchell Management Systems and BIW Cable Systems. He earned his bachelor's degree in chemistry from Boston College.

About Genstruct

Founded in 2002, Genstruct is a systems biology company focused on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. By developing Causal Network(TM) models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct's Consulting Services division engages in short-, mid- and long-term partnerships with top tier pharmaceutical and life sciences companies, to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. Genstruct was awarded the Bio-IT World 2008 Best Practices Award in the Drug Discovery & Development category for its joint collaboration with Sirtris Pharmaceuticals (a GSK company). Genstruct is a privately held company based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.

Genstruct and the Genstruct logo are registered trademarks and Molecular Epistemics, Knowledge Assembly, and Epistemics Engine are trademarks of Genstruct, Inc. All other trademarks or registered trademarks are properties of their respective owners.

Contact:

Karen Higgins

A & E Communications for Genstruct

(610) 831-5723

khiggins@aandecomm.com


'/>"/>
SOURCE Genstruct Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
2. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
3. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
6. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
7. ThermoGenesis Names Tiffany Olson to Board of Directors
8. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
9. eResearchTechnology Names New Chief Financial Officer
10. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
11. The TPAA Names Mark Oelschlager President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... A colony ... among its cells and tissues by delivering pollen and nectar containing nutrients necessary for ... means to stay healthy. , Many recent indicators point to a decline in honey ...
(Date:6/15/2017)... (PRWEB) , ... June 15, 2017 , ... ... it has secured a Series B round of financing in the amount of ... group of private investors participated in the round. , The Series B funding ...
(Date:6/14/2017)... ... June 14, 2017 , ... Slone Partners ... initiative steered by the executive search firm, “Building Value in Precision Medicine: Can ... Directors of Foundation Medicine, led an open discussion with expert panelists Troy Cox, ...
(Date:6/14/2017)... (PRWEB) , ... June 14, 2017 , ... The newest ... discover new therapeutic antibodies using rabbits that express human genes. ATGC, a spin out ... , Founded in 2015, ATGC is a translational genomics company. Its founders are ...
Breaking Biology Technology:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University ... adopting ground breaking 3D fingerprint minutiae recovery and matching technology, pushing ... for use in identification, crime investigation, immigration control, security of access ... ... A research team led by Dr Ajay ...
Breaking Biology News(10 mins):